In Situ Inference of Copy Number Variations in Image-Based Spatial Transcriptomics

Authors:

Abstract
Copy number variations (CNVs) drive cancer progression. So far, spatial CNV inference has relied on whole transcriptome-based sequencing technologies. However, advances in image‐based spatial transcriptomics (iST) now enable high-plex gene measurement in situ. Here, we introduce an approach that adapts CNV inference to iST data, enabling spatial mapping of malignant clones and the tumor microenvironment, at single-cell resolution. Additionally, we assess how panel size and detection efficiency influence CNV inference.
Funding Information
  • Cancerfonden (24-3457)
  • Horizon Europe Mission on Cancer (101136552)
  • Swiss National Science Foundation (222136)
  • MCIN/AEI/10.13039/501100011033 and FSE+ (RYC2022-035848-I)
  • MICIU/AEI/10.13039/501100011033/ FEDER/UE (PID2023-148687OB-I00)
  • European Union’s H2020 research and innovation program (848028)
  • European Research Council (ERC) (810287)
  • Ministerio de Ciencia e Innovación (MCI) (PID2020-115439GB-I00)
  • Ministerio de Ciencia e Innovación (MCI) (PLEC2021-007654)
  • LaCaixa Foundation (HR22-0031)
  • LaCaixa Foundation (HR22-0172)
  • Generalitat de Catalunya through the Suport Grups de Recerca AGAUR (2021-SGR)
  • ERA-NET Neuron/Ministerio de Ciencia e Innovación (MCI) (PCI2022-133012)
  • ASPIRE Award from the Mark Foundation for Cancer Research
  • Scientific Foundation of the Spanish Association Against Cancer
  • U-CAN
  • Erling Persson Foundation